Characterization of systemic amyloid deposits by mass spectrometry.
The human systemic (noncerebral) amyloidoses represent a heterogeneous group of disorders characterized by the widespread deposition of proteins as fibrils in organs or tissues throughout the body. The unequivocal identification of the type of amyloid deposited is critical to the correct diagnosis and treatment of patients with these illnesses. Heretofore, this information was inferred from clinical data, ancillary laboratory tests, and results of immunohistochemical, as well as genetic, analyses. However, to establish definitively the type of amyloid present, the chemical composition of the fibrillar components must be determined. For this purpose, we have developed micro-methods, whereby this information can be obtained by tandem mass spectrometry (MS/MS) using material extracted from formalin-fixed, amyloid-containing tissue biopsy specimens or subcutaneous fat aspirates. The ability to identify precisely the protein nature of the pathologic deposits has diagnostic, therapeutic, and prognostic implications for patients with amyloid-associated disease.
Murphy
Charles L
CL
Human Immunology and Cancer Program, University of Tennessee Graduate School of Medicine, Knoxville, 37920, USA.
Wang
Shuching
S
Williams
Teresa
T
Weiss
Deborah T
DT
Solomon
Alan
A
D000682:Amyloid / Q000032:analysis* / Q000737:chemistry / Q000145:classification / Q000302:isolation & purification*; D000686:Amyloidosis / Q000378:metabolism* / Q000473:pathology*; D006801:Humans; D013058:Mass Spectrometry / Q000379:methods*
D000682:Amyloid